ZA712312B - 4,14-estradiene compounds - Google Patents
4,14-estradiene compoundsInfo
- Publication number
- ZA712312B ZA712312B ZA712312A ZA712312A ZA712312B ZA 712312 B ZA712312 B ZA 712312B ZA 712312 A ZA712312 A ZA 712312A ZA 712312 A ZA712312 A ZA 712312A ZA 712312 B ZA712312 B ZA 712312B
- Authority
- ZA
- South Africa
- Prior art keywords
- estradiene
- compounds
- estradiene compounds
- Prior art date
Links
- JCKUWEBUEPCBKH-LHHMISFZSA-N (8R,9R,10R,13R)-13-methyl-1,2,3,6,7,8,9,10,11,12,16,17-dodecahydrocyclopenta[a]phenanthrene Chemical class C[C@@]12CCC=C1[C@@H]1CCC3=CCCC[C@@H]3[C@H]1CC2 JCKUWEBUEPCBKH-LHHMISFZSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3272370A | 1970-04-28 | 1970-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA712312B true ZA712312B (en) | 1972-01-26 |
Family
ID=21866473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA712312A ZA712312B (en) | 1970-04-28 | 1971-04-13 | 4,14-estradiene compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB1341601A (en) |
| ZA (1) | ZA712312B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW548277B (en) * | 1999-07-16 | 2003-08-21 | Akzo Nobel Nv | Orally active androgens |
| CA2402524C (en) | 2000-03-31 | 2009-11-17 | Richard P. Blye | Methods of making and using 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxy-4-estren-3-one 17.beta.-trans-4-n-butylcyclohexane carboxylate and 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestr-4-en-3-one 17-undecanoate |
| US20030069215A1 (en) | 2001-03-30 | 2003-04-10 | The Government Of The United States Of America, | Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate |
| EP1307471B1 (en) | 2000-07-28 | 2005-05-04 | Akzo Nobel N.V. | 16alpha-methyl or ethyl substituted estrogens |
| WO2002048169A1 (en) * | 2000-12-15 | 2002-06-20 | Akzo Nobel N.V. | 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |
| JP2005510541A (en) * | 2001-03-30 | 2005-04-21 | アメリカ合衆国 | Process for producing 7α, 11β-dimethyl-17β-hydroxyestradi-4,14-dien-3-one and its 17 ester and pharmaceutical preparation containing them |
| UA89964C2 (en) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15beta-substituted steroids having selective estrogenic activity |
-
1971
- 1971-04-13 ZA ZA712312A patent/ZA712312B/en unknown
- 1971-04-27 GB GB1160271*[A patent/GB1341601A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1341601A (en) | 1973-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA71120B (en) | 3,4 dihydro-1,2,3-oxathiazin-4-ones | |
| IL37825A (en) | 1-phenyl-8-chloro-2,3,4-5-tetrahydro-1h-1,5-benzodiazepin-2-one derivatives | |
| IL35743A (en) | 3-isopropyl-5-amino-1,2,4-thiadiazole compounds | |
| HK78076A (en) | 2,2-diaryl-4-(4-aryl-4-hydroxy-piperidino)-butyramides | |
| IL38157A0 (en) | N-substituted-2-carboxy-1-azacyclic compounds | |
| ZA712312B (en) | 4,14-estradiene compounds | |
| CY922A (en) | Benzobicycloalkane compounds | |
| ZA712368B (en) | 5,7-disubstituted-1,9-alkylene-1,4-benzodiazepin-2-ones | |
| PH12851A (en) | 1,2,3,4,5,6-hekahydro-1-oxo-2,6-methano-benzazocines | |
| AU465145B2 (en) | 2, 4-diamino-5-benzylpyrimidines | |
| AU3731471A (en) | Bis-triazole compounds | |
| CA943126A (en) | 4,14-estradiene compounds | |
| ZA711840B (en) | Pge3-type compounds | |
| IL37771A0 (en) | 1,4-benzodioxanes | |
| PH9363A (en) | 5,6-trans-prostaglandins | |
| IL37724A (en) | N-substituted-2,3-dihydro-2-oxo-5-phenyl-1h 1,4-benzodiazepine-1-carboxamides | |
| CA837636A (en) | 1,3-diazacyclo-2,4-butanediones | |
| AU3151271A (en) | Substituted 1, 3-indandiols | |
| IE35197L (en) | 1-phosphinylalkyl-benzo-[1,4]-diazepines | |
| AU464322B2 (en) | 4, 14-estradiene compounds | |
| ZA714743B (en) | Novel 1,2,5-benzotriazepines | |
| IE34884B1 (en) | 1,2,3-trithiane derivatives | |
| PH9684A (en) | 2,6-dinitroanilin derivatives | |
| ZA713471B (en) | 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piperidino)butyramides | |
| AU2775471A (en) | 4, 14-estradiene compounds |